Robert Taub

Robert Taub Overview

Investor Type Angel
Status Active
Investments 6
Portfolio 3
Exits 2
Exits

Robert Taub General Information

Description

Mr. Robert Taub is a Co-Founder and serves as Chairman at Nyxoah. He cofounded and serves as Board Member at LifeBond. He serves as Board Member at Archimedicx and NeuroDerm. He founded Recoly in 1992. Prior to establishing Recoly, Mr. Taub co-founded Octapharma, a Swiss plasma fractionation and pharmaceutical company, which successfully introduced innovative plasma derivative products to the market. Mr. Taub is also the founder of Omrix Biopharmaceuticals, where he served as president, chief executive officer and a member of the board of directors until December 2008 when Omrix was acquired by Johnson and Johnson following its IPO on NASDAQ in April 2006. Prior to Octapharma, Mr. Taub held various general management and sales and marketing positions with Armour Pharmaceutical, Revlon Health Care Group, Baxter Travenol Laboratories, Inc. and Monsanto Company. He has a BA in languages from the University of Antwerp and an MBA from INSEAD in Fontainebleau, France. He co-founded and served as Board Member at LifeBond.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Rue Edouard Belin 12
  • 1435 Mont-Saint-Guibert
  • Belgium
+32 010 00 00 00

Robert Taub Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
GuardKnox 04-Jun-2019 Early Stage VC 0000 Network Management Software Generating Revenue 000000 0000
000000 (00) 06-Oct-2016 00000 00000 000.00 Business/Productivity Software Generating Revenue 000000 0000
0000000000 24-Nov-2015 00 000000000 00.000 Diagnostic Equipment Generating Revenue 000000 0000
00000000000 11-Nov-2015 0000 00000 Other Healthcare Technology Systems Out of Business 000000 0000
LifeBond 05-Aug-2015 Later Stage VC 0000 Surgical Devices Clinical Trials - General 000000 0000
LifeBond 03-Jun-2009 Early Stage VC 000 Surgical Devices Clinical Trials - General 000000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Robert Taub Exits (2)

To view Robert Taub‘s complete exit history, request access >>
Company Name Exit Date Exit Type Exit Size
LifeBond 15-Jan-2020 Merger/Acquisition 0000
00000000000 01-Nov-2017 000 00 00000000

Robert Taub Team (1)

Name Title Deals Funds Boards Office
Robert Taub Angel Investor 0 0 Mont-Saint-Guibert, Belgium

Robert Taub Co-Investors (31)

To view Robert Taub‘s complete co-investor history, request access >>
Name With Exits Lead Partner Series Industry
Gerhard Roiss 2 0 Series chart Industry bar
Paul Achleitner 0 0 Series chart Industry bar
Peter Loescher 0 0 Series chart Industry bar
Faurecia 0 0 Series chart Industry bar
Magna International 0 0 Series chart Industry bar